Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Estimation of fatty liver disease clinical role on glucose metabolic remodelling phenotypes and T2DM onset.

European journal of clinical investigation - 1 Oct 2023

Martinez-Urbistondo Diego, Huerta Ana, Navarro-González David, Sánchez-Iñigo Laura, Fernandez-Montero Alejandro, Landecho Manuel F, Martinez J Alfredo, Pastrana-Delgado Juan C

Abstract excerpt

INTRODUCTION: Metabolic syndrome (MetS), prediabetes (PreDM) and Fatty Liver Disease (FLD) share pathophysiological pathways concerning type 2 diabetes mellitus (T2DM) onset. The non-invasive assessment of fatty liver combined with PreDM and MetS features screening might provide further accuracy in predicting hyperglycemic status in the clinical setting with the putative description of singular phenotypes. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cohort Studies
Share to Diabetes Mellitus, Type 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glucose

Share to Metabolic Syndrome

Share to Non-alcoholic Fatty Liver Disease

Share to Phenotype

Share to Prediabetic State

Share to Risk Factors

Source

Identifiers

PMID: 37303077
DOI: 10.1111/eci.14036

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Estimation of fatty liver disease clinical role on glucose metabolic remodelling phenotypes and T2DM onset.PMID 37303077Read ↗

[Precise clinical classification of metabolic associated fatty liver disease].Semantic proximity Read ↗

Predictive value of the triglyceride-glucose index for metabolic-associated fatty liver disease in individuals with different metabolic obese phenotypesSemantic proximity Read ↗

Phenotypic patterns of metabolic dysfunction‐associated steatotic liver disease in type 2 diabetes: The impact of insulinSemantic proximity Read ↗

Clinical and biochemical phenotypes of Lean MAFLD: machine learning-based biomarker identification and statistical association analysis in a cross-sectional study.Semantic proximity Read ↗

Prevalence of Significant and Advanced Hepatic Fibrosis in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD)Semantic proximity Read ↗

The Health Impact of MAFLD, a Novel Disease Cluster of NAFLD, Is Amplified by the Integrated Effect of Fatty Liver Disease-Related Genetic Variants.Semantic proximity Read ↗

Heterogeneity in risk and potential pathogenic associations of NAFLD among distinct prediabetic phenotypes in young and middle-aged adults.Semantic proximity Read ↗

Molecular characterization of liver steatosis through circulating proteins, metabolites and lipidsSemantic proximity Read ↗

Common Pathogenetic Pathways of Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes MellitusSemantic proximity Read ↗

An Invisible Early Steatosis Phenotype Defined for a Large Population-Based CohortSemantic proximity Read ↗

Effect of cofactors on NAFLD/NASH and MAFLD. A paradigm illustrating the pathomechanics of organ dysfunctionSemantic proximity Read ↗

Evaluation of Liver Metabolism Biomarkers in Metabolic Associated Fatty Liver Disease According to Obesity Phenotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.